Literature DB >> 8925068

Extractionless high-performance liquid chromatographic method for the simultaneous determination of piroxicam and 5'-hydroxypiroxicam in human plasma and urine.

A Avgerinos1, S Axarlis, J Dragatsis, T Karidas, S Malamataris.   

Abstract

A simple and rapid (extractionless) high-performance liquid chromatographic method with UV detection, at 330 nm, was developed for the simultaneous determination of piroxicam and its major metabolite, 5'-hydroxypiroxicam, in human plasma and urine. Acidified plasma and alkali-treated urine samples are used and naproxen is added as internal standard. The separation is performed at 40 degrees C on a C18 Spherisorb column with acetonitrile--0.1 M sodium acetate (33:67, v/v, pH 3.3) as mobile phase. The retention time is 2.2 min for 5'-hydroxypiroxicam, 2.6 min for piroxicam and 3.2 min for naproxen. The detection limit is 0.05 micrograms/ml using a 100-microliters loop.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8925068     DOI: 10.1016/0378-4347(95)00248-h

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  1 in total

1.  Further evidence for interethnic differences in the oral pharmacokinetics of meloxicam.

Authors:  Miriam Del Carmen Carrasco-Portugal; José Carlos Aguilar-Carrasco; Miguel Luján; Gerardo Reyes-García; Roberto Medina-Santillán; Francisco J Flores-Murrieta
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.